Get started
Author

Melissa Daou

TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
2024 · Nicola Alesi, Damir Khabibullin, et al. · Nature Communications · 61
PDF
Virtual reality for healthcare: A scoping review of commercially available applications for head-mounted displays
2023 · Samar Helou, Nour Khalil, et al. · Digital Health · 50
PDF
Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines
2022 · Nelly Ziade, Ihsane Hmamouchi, et al. · Rheumatology International · 27
PDF
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell Carcinoma
2025 · Chris Labaki, Eddy Saad, et al. · Journal of Clinical Oncology · 18
Benchmarking mismatch repair testing for patients with cancer receiving immunotherapy
2023 · Elias Bou Farhat, Elio Adib, et al. · Cancer Cell · 12
Modulation of infiltrating CD206 + macrophages restricts progression of pulmonary lymphangioleiomyomatosis
2025 · Heng-Jia Liu, Remi Diesler, et al. · European Respiratory Journal · 8
PDF
Cost of bladder cancer in Lebanon before and after the economic collapse: a probabilistic modeling study
2023 · Elie Raad, Samar Helou, et al. · International Journal for Equity in Health · 6
PDF
Association of Social Determinants of Health with Utilization of SGLT2 Inhibitors and GLP1 Receptor Agonists: A Systematic Review and Meta-Analysis
2026 · Nisarg Shah, Johann Alexandre Chafa Edjimbi, et al. · Journal of General Internal Medicine · 5
Analysis of ASS1 gene in ten unrelated middle eastern families with citrullinemia type 1 identifies rare and novel variants
2023 · Melissa Daou, Mirna Souaid, et al. · Molecular Genetics & Genomic Medicine · 5
PDF
Ensuring Care Continuity in Extreme Crises: A Participatory Action Research Approach
2022 · Melissa Daou, Samar Helou, et al. · Studies in health technology and informatics · 4
PDF
Benchmarking mismatch repair testing for patients with cancer receiving immunotherapy
2024 · Elias Bou Farhat, Elio Adib, et al. · Cancer Cell · 3
Abstract B019: Clinical and molecular characterization of chromophobe renal cell carcinoma: A focus on immunotherapy based regimens and the tumor immune microenvironment
2023 · Michel Alchoueiry, Chris Labaki, et al. · Cancer Research · 1
mTORC1 activation induces B7-H3-dependent metabolic reprogramming in renal cell carcinoma (RCC)
2026 · Keying Li, Heng Du, et al. · Oncogene
PDF
Persistent Acromegaly Unmasked: A Jejunal Neuroendocrine Tumor Secreting Growth Hormone Releasing Hormone
2026 · Melissa Daou, Gary Israel, et al. · AACE Endocrinology and Diabetes
PDF
A Case Report of Mixed Acinar-Neuroendocrine Pancreatic Carcinoma: A Rare Subtype of Pancreatic Cancer
2025 · Thai Hau Koo, Venkata Sunkesula, et al. · Case Reports in Gastroenterology
PDF
52 Ferroptosis Suppressor Protein 1 is a Potent and Targetable Inhibitor of Ferroptosis in Chromophobe Renal Cell
2024 · Samer Salem, Nadine Mahmoud, et al. · The Oncologist
Benchmarking mismatch repair testing for patients with cancer receiving immunotherapy.
2024 · Elias Bou Farhat, Elio Adib, et al. · Journal of Clinical Oncology
Works count: 17
Citation count: 200
H-index: 6
I10-index: 5
Year
Topic
Type